Xm archive tissue molec anal
CPT code 88363 covers laboratory examination of archived (previously stored) tissue samples using molecular analysis techniques to detect genetic or protein markers. This typically involves analyzing preserved tissue from a prior biopsy or surgery to provide additional diagnostic information.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Document the original specimen collection date and accession number to prove the tissue is truly 'archived' and not from a current case
Impact: Prevents denials for incorrect code selection; using 88363 instead of initial analysis codes can result in $50-200 difference depending on the actual test performed
Bill 88363 per specimen block retrieved and processed, not per molecular test performed on the extracted material
Impact: 88363 represents tissue preparation only ($22.64); the actual molecular analysis (PCR, FISH, etc.) is billed separately with codes like 88364-88377, potentially adding $100-500 per analysis
Link diagnosis codes that justify the medical necessity of retrieving archived tissue, such as change in treatment plan or newly available targeted therapies
Impact: Reduces denial rate by 30-40% when clear clinical necessity is established through appropriate ICD-10 codes
Verify whether the requesting physician ordered tissue retrieval specifically or if it's included in the molecular test order, as some payers bundle preparation into the analysis code
Impact: Prevents unbundling denials that can trigger recoupment of the $18-23 payment plus potential audit risk
For Medicare, ensure the test meets LCD/NCD requirements for molecular testing coverage before retrieving archived tissue
Impact: Avoids non-covered charges; tissue retrieval costs are lost if the subsequent molecular test is denied
Document any specimen-specific challenges (small tissue quantity, poor fixation, age of block) that required additional technical work
Supports medical necessity if appealing denials; may justify modifier use in edge cases though does not increase base reimbursement
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.